Managing data effectively can be challenging in any industry. But it’s especially difficult in pharmaceuticals, which faces ...

Ipsen has announced that it will be gaining exclusive global rights to Biomunex Pharmaceuticals’ pre-clinical T cell engager ...

The National Institute for Health and Care Excellence (NICE) has recommended Immunocore’s Kimmtrak (tebentafusp) as the first ...

Health equity, a fundamental human right, remains elusive for many. As health communicators, we play a crucial role in addressing these disparities, bridging gaps and supporting underserved ...

GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

A UK study has shown that a drug currently used to treat severe asthma could be re-purposed for use in emergency settings, ...

Galderma’s nemolizumab has been shown to improve the core signs and symptoms of prurigo nodularis, according to phase 3 ...

The development of all treatments, including vaccines, is dependent on people taking part in clinical trials but this can be ...